Abiopharma

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Appoints Richard Buzbuzian as CEO to Lead Nationwide Commercialization of Innovative, Clinically Validated Hangover Remedy and Alcohol Metabolism Accelerant

(30% Negative) EQUITY LIFESTYLE PROPERTIES INC (ELS) Reports Q2 2026 Financial Results

New Form ARS - Pathfinder Bancorp, Inc. <b>Filed:</b> 2026-04-22 <b>AccNo:</b> 0001193125-26-169392 <b>Size:</b> 2 MB

(99% Neutral) KUSTOM ENTERTAINMENT, INC. (KUST) Files Form 8-K

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-04-22 <b>AccNo:</b> 0001918704-26-010490 <b>Size:</b> 480 KB

General Announcement: BALLOTING RESULTS PRESS RELEASE AND CORPORATE PRESENTATION

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-04-22 <b>AccNo:</b> 0000950103-26-006025 <b>Size:</b> 140 KB

ELBIT SYSTEMS LTD (ESLT) Files Form 6-K

Toro Corp. Declares Special Dividend of $0.90 Per Share

FERRARI TO ANNOUNCE FIRST QUARTER 2026 FINANCIAL RESULTS ON MAY 5

UNI-FUELS HOLDINGS LTD (UFG) Files Form 6-K

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-04-22 <b>AccNo:</b> 0001193125-26-169377 <b>Size:</b> 741 KB

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-04-22 <b>AccNo:</b> 0001918704-26-010489 <b>Size:</b> 666 KB

Uni-Fuels Reports Audited FY2025 Results with 70% Revenue Growth and Expanding Global Operations

Xenetic Biosciences, Inc. Announces Abstract Acceptance for Presentation at the 2026 ASCO Annual Meeting